We probably should talk more about the fact that
JOE KENNEDY OWNS STOCK IN GILEAD
Gilead Sciences announced its Covid-19 therapy drug, remdesivir, will cost private insurers $520 for a single vial, hundreds of times its production cost, which researchers have estimated at 93 cents per dose. interc.pt/2ZXPyy3
17
1,152
44
5,646





